Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9458-9469

  Beck, Z Q ^a   Lin, Y C ^a   Elder, J H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PROTEINASE; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BACTERIOPHAGE; ENZYME SPECIFICITY; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

AMINO ACID SUBSTITUTION; ANIMALS; CATS; ENDOPEPTIDASES; HIV-1; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY; VIRAL PROTEINS;

EID: 0034818269     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9458-9469.2001     Document Type: Article

References (34)

1. Rapid in situ neutralization protocols for Boc and Fmoc solid-phase chemistries
2. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development
3. Analysis of subsite preferences of HIV-1 proteinase using MA/CA junction peptides substituted at the P3-P1' positions
4. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors
5. Novel Gag-Pol frameshift site in human immunodeficiency virus type 1 variants resistant to protease inhibitors
6. Subsite preferences of retroviral proteinases
7. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: Structure-based drug design and the resistance problem
8. Structural mechanisms of HIV drug resistance
9. A continuous fluorometric assay for the feline immunodeficiency virus protease
10. Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus
11. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing hydrophobic-hydrophobic- or aromatic pro-cleavage sites
12. Mutations that alter the activity of the Rous sarcoma virus protease
13. An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase
14. Molecular analysis of the feline immunodeficiency virus protease: Generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases
15. Analysis of the S3 and S3′ subsite specificities of feline immunodeficiency virus (FIV) protease: Development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo
16. Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease
17. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease
18. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients
19. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors
20. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid
21. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites
22. Rational design of peptide-based HIV proteinase inhibitors
23. On the size of the active site in proteases
24. Mutations in retroviral genes associated with drug resistance
25. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high-yield assembly of difficult sequences
26. Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries
27. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease
28. A simple, continuous fluorometric assay for HIV protease
29. Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity
30. Studies on the role of the S4 substrate binding site of HIV proteinases
31. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases
32. Structure-based inhibitors of HIV-1 protease
33. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus
34. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites